Johnson & Johnson lost a $5.7 million verdict on Thursday in the first test case over one of its newest pelvic mesh slings, which is among dozens of similar devices named in thousands of lawsuits across the country.
The verdict, by a jury in Bakersfield, Calif., is the latest to hit Johnson & Johnson, whose Ethicon Inc. subsidiary has lost verdicts over its other mesh devices. The trial, which began on Jan. 26, was the first over Ethicon’s TVT-Abbrevo device, which is used to treat urinary incontinence caused from sudden movements. The plaintiff, Coleen Perry, had alleged that she had pain and continued urinary problems after having the device implanted in 2011.
